Why the study?
Do acute coronary vasodilators (nifedipine, nicardipine, nitroglycerin) affect atrial natriuretic peptide and the renin-angiotensin-aldosterone system in normal subjects and patients with essential hypertension?
Do acute coronary vasodilators (nifedipine, nicardipine, nitroglycerin) affect atrial natriuretic peptide and the renin-angiotensin-aldosterone system in normal subjects and patients with essential hypertension?
Nifedipine acutely elevates ANP and RAAS components in normal subjects but not in hypertensive patients, an effect not seen with nicardipine or nitroglycerin.
Answers are grounded in this paper and cite their sources.
Hypertension may blunt nifedipine effects on ANP/RAAS; hypothesis-generating and should not yet change practice.
Acute effects of coronary vasodilators (nifedipine, nicardipine, and nitroglycerin) on atrial natriuretic peptide (ANP) and the renin-angiotensin-aldosterone system were studied in normal subjects and patients with essential hypertension. Nifedipine lowered blood pressure both in normal subjects and in patients and elevated ANP, plasma renin activity, and angiotensin II in normal subjects but not in hypertensive patients. Nicardipine lowered blood pressure but failed to elevate ANP and angiotensin II in normal subjects. Nitroglycerin failed to elevate ANP in normal subjects.
No takes yet. Share an insight, caveat, or question.
Iwasaki et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: